Mortality up with impaired LV global longitudinal strain in CKD

Mortality up with impaired LV global longitudinal strain in CKD

(HealthDay)—Severely impaired left ventricular (LV) global longitudinal strain (GLS) is associated with worse prognosis in predialysis and dialysis patients, according to a study published in the Aug. 1 issue of The American Journal of Cardiology.

Liselotte C.R. Hensen, M.D., from Leiden University Medical Center in the Netherlands, and colleagues measured LV GLS in a retrospective cohort of predialysis and dialysis (chronic kidney disease stage 3b to 5) who underwent clinically indicated echocardiography. They divided patients according to quartiles of LV GLS.

Sixty-five and 35 percent of the 304 patients were in predialysis and , respectively. The researchers found that 34 percent of patients underwent renal transplantation during a median follow-up of 29 months, and 36 percent died. Compared with other groups, patients with the worst function (LV GLS ≤10.6 percent) showed significantly worse prognosis. After adjustment for age, gender, albumin levels, atrial fibrillation, and renal transplantation, LV GLS ≤10.6 percent was significantly associated with increased risk of all-cause mortality (hazard ratio, 2.18).

"In conclusion, in predialysis and , severely impaired LV GLS is independently associated with an increased risk of mortality," the authors write.

One author disclosed financial ties to Abbott Vascular.

More information: Abstract
Full Text

Journal information: American Journal of Cardiology

Copyright © 2017 HealthDay. All rights reserved.

Citation: Mortality up with impaired LV global longitudinal strain in CKD (2017, July 13) retrieved 24 April 2024 from https://medicalxpress.com/news/2017-07-mortality-impaired-lv-global-longitudinal.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Low albumin predicts mortality in renal replacement therapy

0 shares

Feedback to editors